TumorDiagnostik & Therapie

LinksSchließen

Referenz

Shanafelt TD, Wang V, Kay NE. et al.
A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy Vs. Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL): A Trial of the ECOG-ACRIN Cancer Research Group (E1912).

Blood 2018;
132: LBA-4

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: